Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 12

Results: 7

Acknowledgement to Referees: Acknowledgement to Referees: Acknowledgement to Referees.
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 875, doi. 10.1007/s40261-024-01412-9
Publication type:
Article
A Phase I Clinical Trial to Evaluate the Bioequivalence of an Adalimumab Biosimilar Adalimumab-WIBP and Humira®: Bioequivalence Trial of Adalimumab-WIBP and Humira®: S. Hu et al.
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 951, doi. 10.1007/s40261-024-01409-4
By:
- Hu, Shengling;
- Liu, Yang;
- Yang, Lu;
- Yang, Yunkai;
- Long, Feiguang;
- Bao, Hongying;
- Zhang, Huijun;
- Yue, Xin;
- Zhang, Jiayou;
- Wang, Zejun;
- Huang, Chaolin;
- Wang, Jingli;
- Xia, Liu;
- Pan, Yongbing;
- Zhang, Yuntao;
- Gong, Fengyun
Publication type:
Article
A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder: Evaluating New Injection Locations for Monthly Extended-Release Buprenorphine: C. M. Laffont et al
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 939, doi. 10.1007/s40261-024-01406-7
By:
- Laffont, Celine M.;
- Lapeyra, Olga;
- Mangal, Dipti;
- Dobbins, Robert
Publication type:
Article
A Network Meta-Analysis of Vasodilator Therapies in Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: Insights for Optimizing Hemodynamics: Vasodilator Therapy for PH in Patients Undergoing Mitral Valve Replacement Surgery: A. Elrosasy et al
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 897, doi. 10.1007/s40261-024-01404-9
By:
- Elrosasy, Amr;
- Maher, Ahmed;
- Ramadan, Abdelraouf;
- Hamam, Nada G.;
- Soliman, Mohamed;
- Kamal, Sara K.;
- Milik, Beshoy Emad;
- Shahat, Abdullah Ali;
- Kamel, Menna Nabil;
- Ali, Ahmed Abdeltawab;
- Hassan, Loay Abdelnabi;
- Zabady, Ahmed;
- Zeid, Mohamed Abo;
- Abdelmottaleb, Wael;
- Nassar, Sameh
Publication type:
Article
Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients: Ferric Carboxymaltose in Heart Failure: A. M. Taha et al.
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 879, doi. 10.1007/s40261-024-01401-y
By:
- Taha, Amira Mohamed;
- Elsaeidy, Ahmed Saad;
- Nada, Sarah A.;
- Sharma, Sadish;
- Ghonaim, Mohamed M.;
- Ahsan, Areeba;
- Mourid, Marina Ramzy;
- Abouelmagd, Khaled
Publication type:
Article
Cost-Effectiveness Analysis of Adjuvant Pertuzumab and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer in Japan: CEA of Adjuvant Pertuzumab and Trastuzumab in HER2+ eBC in Japan: C. Nusawat et al.
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 927, doi. 10.1007/s40261-024-01399-3
By:
- Nusawat, Chanon;
- Sato, So;
- Watanabe, Hideaki;
- Konishi, Takaaki;
- Yamana, Hayato;
- Yasunaga, Hideo
Publication type:
Article
Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz®) in Europe: A Prescriber Survey: Evaluation of Tofacitinib aRMM: J. Wu et al.
Published in:
Clinical Drug Investigation, 2024, v. 44, n. 12, p. 961, doi. 10.1007/s40261-024-01408-5
By:
- Wu, Joanne;
- Koram, Nana;
- Asomaning, Kofi;
- Merchant, Lubna;
- Massouh, Robert;
- Nagy, Edward;
- Khalid, Subhan;
- Walsh, Laura;
- Bosan, Rafia;
- Cantos, Krystal
Publication type:
Article

Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 12

Acknowledgement to Referees: Acknowledgement to Referees: Acknowledgement to Referees.

A Phase I Clinical Trial to Evaluate the Bioequivalence of an Adalimumab Biosimilar Adalimumab-WIBP and Humira<sup>®</sup>: Bioequivalence Trial of Adalimumab-WIBP and Humira<sup>®</sup>: S. Hu et al.

A Network Meta-Analysis of Vasodilator Therapies in Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: Insights for Optimizing Hemodynamics: Vasodilator Therapy for PH in Patients Undergoing Mitral Valve Replacement Surgery: A. Elrosasy et al

Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients: Ferric Carboxymaltose in Heart Failure: A. M. Taha et al.

Cost-Effectiveness Analysis of Adjuvant Pertuzumab and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer in Japan: CEA of Adjuvant Pertuzumab and Trastuzumab in HER2+ eBC in Japan: C. Nusawat et al.

Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz<sup>®</sup>) in Europe: A Prescriber Survey: Evaluation of Tofacitinib aRMM: J. Wu et al.